Van Mossevelde Sara, van der Zee Julie, Cruts Marc, Van Broeckhoven Christine
Center for Molecular Neurology, VIB, Universiteitsplein 1, 2610 Antwerp, Belgium; Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium; Department of Neurology and Memory Clinic, Hospital Network Antwerp Hoge Beuken, Commandant Weynsstraat 165, 2660 Hoboken, Belgium; Department of Neurology, Antwerp University Hospital, Wilrijkstraat 10, 2650 Edegem, Belgium.
Center for Molecular Neurology, VIB, Universiteitsplein 1, 2610 Antwerp, Belgium; Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium.
Curr Opin Genet Dev. 2017 Jun;44:117-124. doi: 10.1016/j.gde.2017.02.008. Epub 2017 Mar 17.
Patient carriers of a C9orf72 repeat expansion exhibit remarkable heterogeneous clinical and pathological characteristics suggesting the presence of modifying factors. In accordance with other repeat expansion diseases, repeat length is the prime candidate as a genetic modifier. Observations of earlier onset ages in younger generations of large families suggested a mechanism of disease anticipation. Yet, studies of repeat size and onset age have led to conflicting results. Also, the correlation between repeat size and diagnosis is poorly understood. We review what has been published regarding C9orf72 repeat size as modifier for phenotypic characteristics. Conclusive evidence is lacking, partly due to the difficulties in accurately defining the exact repeat size and the presence of repeat variability due to somatic mosaicism.
携带C9orf72重复序列扩增的患者表现出显著的临床和病理特征异质性,提示存在修饰因子。与其他重复序列扩增疾病一样,重复序列长度是作为遗传修饰因子的主要候选因素。对大家庭中较年轻一代发病年龄提前的观察提示了疾病早现的机制。然而,关于重复序列大小与发病年龄的研究结果相互矛盾。此外,重复序列大小与诊断之间的相关性也知之甚少。我们综述了已发表的关于C9orf72重复序列大小作为表型特征修饰因子的研究。由于难以准确确定确切的重复序列大小以及存在体细胞嵌合导致的重复序列变异性,确凿证据尚缺。